Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1616 1633 1636
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19568680 | YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18271536 | TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18314810 | Site-Specific Gene Modifications | Final Rejection | The Regents of the University of California |
| 17626674 | MULTILAMELLAR RNA NANOPARTICLES | Final Rejection | University of Florida Research Foundation, Inc. |
| 18698888 | LIPID NANOPARTICLES FOR DRUG DELIVERY TO MICROGLIA IN THE BRAIN | Non-Final OA | Massachusetts Institute of Technology |
| 17791504 | LONG-ACTING THERAPEUTIC AGENT COMBINATIONS AND METHODS THEREOF | Final Rejection | University of Washington |
| 18280048 | CHAPERONIN-CONTAINING TCP-1 INHIBITORS FOR THE TREATMENT OF CANCER | Non-Final OA | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. |
| 17950573 | PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF | Final Rejection | THE GEORGE WASHINGTON UNIVERSITY |
| 17914408 | A METHOD AND SYSTEM FOR INTRODUCING ONE OR MORE EXOGENOUS SUBSTANCES INTO AN IMMUNE CELL | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 17787089 | SYNTHETIC PROCESSES AND INTERMEDIATES | Non-Final OA | ARBUTUS BIOPHARMA CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy